European Stocks Advance as Investors Weigh Ukraine, ECB

European stocks advanced in the final minutes of trading, after remaining little changed for much of the day, as European Union governments weighed further sanctions on Russia and as investors awaited this week’s European Central Bank meeting.

Novartis AG climbed the most in almost three years after saying its experimental heart drug showed better results than standard therapy. Iliad SA tumbled 8.8 percent after people familiar with the matter said it is talking to private-equity firms to make an improved offer for T-Mobile US Inc.